BioVie Statistics
Total Valuation
BioVie has a market cap or net worth of $15.31 million. The enterprise value is $6.61 million.
| Market Cap | 15.31M |
| Enterprise Value | 6.61M |
Important Dates
The last earnings date was Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BioVie has 7.54 million shares outstanding. The number of shares has increased by 390.46% in one year.
| Current Share Class | 7.54M |
| Shares Outstanding | 7.54M |
| Shares Change (YoY) | +390.46% |
| Shares Change (QoQ) | +5.05% |
| Owned by Insiders (%) | 0.86% |
| Owned by Institutions (%) | 23.51% |
| Float | 7.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.49 |
| P/TBV Ratio | 1.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.59, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.59 |
| Quick Ratio | 2.93 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,265.39 |
Financial Efficiency
Return on equity (ROE) is -150.76% and return on invested capital (ROIC) is -94.67%.
| Return on Equity (ROE) | -150.76% |
| Return on Assets (ROA) | -79.06% |
| Return on Invested Capital (ROIC) | -94.67% |
| Return on Capital Employed (ROCE) | -216.67% |
| Weighted Average Cost of Capital (WACC) | 8.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.70M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.36% in the last 52 weeks. The beta is 0.74, so BioVie's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +20.36% |
| 50-Day Moving Average | 1.73 |
| 200-Day Moving Average | 1.49 |
| Relative Strength Index (RSI) | 55.10 |
| Average Volume (20 Days) | 12,193,507 |
Short Selling Information
The latest short interest is 1.25 million, so 16.63% of the outstanding shares have been sold short.
| Short Interest | 1.25M |
| Short Previous Month | 800,586 |
| Short % of Shares Out | 16.63% |
| Short % of Float | 16.78% |
| Short Ratio (days to cover) | 0.20 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -22.65M |
| Pretax Income | -22.07M |
| Net Income | -22.12M |
| EBITDA | -22.47M |
| EBIT | -22.65M |
| Earnings Per Share (EPS) | -$3.05 |
Balance Sheet
The company has $8.98 million in cash and $275,430 in debt, with a net cash position of $8.70 million or $1.15 per share.
| Cash & Cash Equivalents | 8.98M |
| Total Debt | 275,430 |
| Net Cash | 8.70M |
| Net Cash Per Share | $1.15 |
| Equity (Book Value) | 10.27M |
| Book Value Per Share | 1.36 |
| Working Capital | 9.85M |
Cash Flow
| Operating Cash Flow | -19.02M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 178,341 |
| Net Borrowing | n/a |
| Free Cash Flow | -19.02M |
| FCF Per Share | -$2.52 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BioVie does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -390.46% |
| Shareholder Yield | -390.46% |
| Earnings Yield | -144.44% |
| FCF Yield | -124.25% |
Analyst Forecast
The average price target for BioVie is $5.26, which is 159.11% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.26 |
| Price Target Difference | 159.11% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 7, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |